✨ Free AI Report
Minerva Surgical, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Minerva Surgical, Inc.
Company Research

Minerva Surgical, Inc.: Business Overview, Financials & Competitive Analysis

Minerva Surgical, Inc. scores 3/10 on the AskCyborg Cyborg Score (Challenged). High-value market segment with unmet needs, but execution risks and financial constraints present substantial challenges to viability. Despite addressing a substantial market opportunity in women's health, Minerva faces significant headwinds including minimal TTM revenue (~$12M), persistent operating losses (-$6.1M), and a reverse stock split history indicating compliance struggles. The.

What is Minerva Surgical, Inc.'s industry? Minerva Surgical, Inc. (minervasurgical.com) operates in Medical Devices - Women's Health / Gynecology. AskCyborg classifies Minerva Surgical, Inc. under Medical Devices - Women's Health / Gynecology in its company registry.

Minerva Surgical is a commercial-stage medical technology company focused on developing minimally invasive solutions for abnormal uterine bleeding (AUB), a condition affecting roughly 1 in 5 women. The company offers ...

3/ 10Challenged

Cyborg Score thesis

High-value market segment with unmet needs, but execution risks and financial constraints present substantial challenges to...

Read the full analyst-debate transcript →
Industry Medical Devices - Women's Health / Gynecology
2 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 19, 2026
AI-Generated Research
30+ Page Report

Get the Latest Minerva Surgical, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Minerva Surgical, Inc.

AskCyborg analysts argue the bull and bear cases for Minerva Surgical, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Minerva Surgical, Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Minerva Surgical, Inc. Overview

Pro stress-test →

Minerva Surgical is a commercial-stage medical technology company focused on developing minimally invasive solutions for abnormal uterine bleeding (AUB), a condition affecting roughly 1 in 5 women. The company offers alternatives to hysterectomy including flagship products like Symphion and Minerva ES, positioning itself in the high-value women's health market where unmet needs remain substantial.

Strategic Profile

Pro stress-test →

Founded in 2008 by medical device veterans, Minerva leverages deep industry expertise to create innovative gynecological solutions for use in hospitals, ambulatory surgical centers, and physician offices. The company differentiates through its broad product portfolio addressing multiple anatomies and treatment settings, though it remains in early commercial stage with revenue challenges limiting its competitive positioning.

Competitive Landscape

Pro stress-test →

Minerva competes in the women's health endometrial ablation and gynecological device space with established players, though specific direct competitors were not detailed in available sources. The company's minimally invasive positioning versus traditional hysterectomy provides a broad competitive advantage, but larger medical device manufacturers with greater resources and market presence represent structural competitive challenges.

Industry Context

Minerva Surgical, Inc. operates in Medical Devices - Women's Health / Gynecology.

Key facts

Founded: 2008 · Headquarters: Santa Clara, California · Revenue: $12M (TTM)

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Minerva Surgical, Inc..

  • Addresses abnormal uterine bleeding affecting ~20% of women, representing a substantial untreated market opportunity
  • Product portfolio includes multiple FDA-cleared minimally invasive devices (Symphion, Minerva ES, Resectr) enabling alternatives to hysterectomy
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • October 2023Completed 20-for-1 reverse stock split to maintain NASDAQ listing compliance
  • August 2023Reported Q2 2023 revenue of $13.4M (3% increase YoY) with guidance of $52-55M for full-year 2023
  • +1 moreTrack every material event for Minerva Surgical, Inc. as it happens. Explore monitoring →
Get alerted when Minerva Surgical, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Compare Minerva Surgical, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Minerva Surgical, Inc. operates in Medical Devices - Women's Health / Gynecology. See how the rest of the sector scores on the Cyborg framework.

Browse Medical Devices - Women's Health / Gynecology research →
NEW · MCP server

Ask your AI assistant about Minerva Surgical, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Minerva Surgical, Inc. and its top competitor on Cyborg Score”
“What did Minerva Surgical, Inc. do this quarter?”
“Is Minerva Surgical, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com · Terms of Service

Frequently asked questions

What does Minerva Surgical, Inc. do?+
Minerva Surgical is a commercial-stage medical technology company focused on developing minimally invasive solutions for abnormal uterine bleeding (AUB), a condition affecting roughly 1 in 5 women. The company offers ...
What is Minerva Surgical, Inc.'s Cyborg Score?+
Minerva Surgical, Inc. has a Cyborg Score of 3/10 (Challenged). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Minerva Surgical, Inc.'s main competitors?+
Named competitors include Endometrial ablation devices, Hysterectomy alternatives. The full competitive landscape is in the AskCyborg report.
How can I get the full Minerva Surgical, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Minerva Surgical, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Minerva Surgical, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual